ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,007Medicare Part D Prescriptions Filled, Including Refills

Rank: 248 out of 1111

$537K Total Retail Price of All Prescriptions

Rank: 190 out of 1111

544 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 544 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 544 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 6,918 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 476 429 1 3
OMEPRAZOLE 282 247 2 4
SIMVASTATIN 257 236 3 5
LISINOPRIL 192 171 4 2
AMLODIPINE BESYLATE 190 150 5 7
MELOXICAM 168 151 6 18
FLUTICASONE PROPIONATE 154 131 7 27
CITALOPRAM HBR 153 105 8 14
TRAMADOL HCL-ACETAMINOPHEN 150 133 9 214
HYDROCODONE-ACETAMINOPHEN 149 118 S3 10 1
TRAZODONE HCL 117 87 11 32
FUROSEMIDE 116 99 12 6
POTASSIUM CHLORIDE 116 109 12 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 101 14 23
HYDROCHLOROTHIAZIDE 115 104 14 11
PRAVASTATIN SODIUM 113 99 16 17
ATORVASTATIN CALCIUM 108 99 17 15
METFORMIN HCL 103 92 18 8
CEFDINIR 99 79 19 209
GABAPENTIN 94 87 20 10
PANTOPRAZOLE SODIUM 93 76 21 50
TAMSULOSIN HCL 91 88 22 28
ETODOLAC 83 79 23 137
METOPROLOL SUCCINATE 78 74 24 20
ALENDRONATE SODIUM 76 75 25 35
ZOLPIDEM TARTRATE 72 45 26 16
LOSARTAN-HYDROCHLOROTHIAZIDE 69 65 27 72
GLIMEPIRIDE 67 66 28 61
METOPROLOL TARTRATE 66 60 29 12
ALLOPURINOL 63 54 30 36
AZITHROMYCIN 63 54 30 39
CYMBALTA 61 40 32 40
LOVASTATIN 58 54 33 41
LIPITOR 57 57 34 116
TRAMADOL HCL 54 48 35 13
TRIAMTERENE-HCTZ 53 51 36 80
NAMENDA 53 53 36 31
PROPRANOLOL HCL 52 37 38 124
SYNTHROID 52 52 38 63
ESTRADIOL 51 34 R 40 102
METFORMIN HCL ER 50 45 41 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.